Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05389_nanopub.RAwcPld0gfAj9Cqq_nBJzyAM9_fbWs31U7B9CoIhta7cs#assertion>. }
Showing items 1 to 15 of
15
with 100 items per page.
- drugbank:DB05389 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05389 label "WF10 [drugbank:DB05389]" assertion.
- drugbank:DB05389 seeAlso DB05389 assertion.
- drugbank:DB05389 description "WF10 is a chlorite-based, immunomodulating drug is developed by Nuvo Research Inc. Certain preclinical evidence and clinical pilot data suggest that WF10 may be effective in treating certain cancers. The Corporation believes the research to-date demonstrates that WF10 acts on macrophages (a type of white blood cell) by modulating the balance between inflammation and phagocytosis, a state in which the body digests foreign, potentially harmful substances. The Corporation has commenced a Phase II clinical trial in an effort to demonstrate the efficacy of WF10 in combination with Xeloda (capecitabine) in the treatment of pancreatic cancer. The trial is being conducted in Germany at the University of Heidelberg and the National Centre for Tumor Diseases." assertion.
- drugbank:DB05389 identifier "drugbank:DB05389" assertion.
- drugbank:DB05389 title "WF10" assertion.
- drugbank:DB05389 drugbank_vocabulary:x-pubchemcompound pubchem.compound:3000391 assertion.
- drugbank:DB05389 drugbank_vocabulary:x-chemspider chemspider:2272021 assertion.
- drugbank:DB05389 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05389 drugbank_vocabulary:drugbank-id "DB05389" assertion.
- drugbank:DB05389 bio2rdf_vocabulary:x-identifiers.org DB05389 assertion.
- drugbank:DB05389 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05389" assertion.
- drugbank:DB05389 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05389 bio2rdf_vocabulary:identifier "DB05389" assertion.
- drugbank:DB05389 drugbank_vocabulary:x-wikipedia wikipedia:WF10 assertion.